The clinical association of insulin resistance (IR), hypertension, obesity, dyslipidaemia (increased VLDL and decreased HDL-cholesterol concentration in plasma), higher plasma PAI ±1 concentrations and decreased arterial distensibility, is widely known as the insulin resistance syndrome [1±3]. A strong association between the occurrence of insulin resistance syndrome and cardiovascular diseases (mainly coronary heart diseases) has been also demonstrated [1±2]. Nevertheless, hyperinsulinaemia is also in itself an independent risk factor for cardiovascular diseases [4] probably due to the capacity of insulin to directly promote the growth of vascular cells and atherosclerosis [4] .
rine fetal liver and promote growth in both human bone marrow and circulating erythroid progenitor cells [6±9] .
Our data let indicate that hyperinsulinaemia/insulin resistance could stimulate erythroid progenitors proliferation and so result in an increase of RBC (red blood cell) mass. Because RBC mass is a risk factor for cardiovascular diseases [10] , such a mechanism could explain, at least in part, the high risk of cardiovascular diseases in patients with hyperinsulinaemia/insulin resistance.
Subjects and methods
Subjects. This study is part of the InCHIANTI Study, a prospective population-based study of older people, designed by the laboratory of Clinical Epidemiology of the Italian National Research Council of Aging, (INRCA, Florence, Italy) and carried out in the Chianti geographic area (Tuscany, Italy). This database includes data from 1440 participants (between 20 and 102 years of age) randomly selected from the residents in the two municipalities of Greve in Chianti and Bagno a Ripoli using a multistage stratified sampling method [11] . Data collection started in September 1998 and was completed in March 2000.
Our study population consisted of 600 subjects between 22 and 99 years of age, selected from the cohort from Greve in Chianti, excluding those affected by diabetes mellitus and prevalent clinical cardiovascular and haematological diseases. Diabetes mellitus was diagnosed according to the criteria of the American Diabetes Association [12] . Patients with prevalent clinical cardiovascular diseases were excluded to avoid interference on the degree of IR within, and among, each group.
Subjects were asked whether they had received any medical care during the past 5 years and, if so, the reason and speciality. The names of the drugs and dosages prescribed were also recorded. Subjects taking drugs known to interfere with glucose (i. e. sulphonylureas, biguanides, insulin) or erythrocytes (i. e. cytostatics, erythropoietin) metabolism were also excluded from the study.
All subjects gave their informed consent before participating in the study which was approved by the ethical committee of our institutions.
Anthropometric determinations. Weight and height were measured using standard techniques. BMI was calculated as weight (kg) divided by height (cm) squared. The waist circumference was measured at the midpoint between the lower rib margin and the iliac crest (normally umbilical level) and hip circumference at the level of trochanter. Both were measured to the nearest 0.5 cm with a plastic tape measure and the waist-tohip ratio (WHR) was calculated.
Metabolic and cardiovascular determinations. Serum glucose and insulin were on a blood sample collected in the morning after the participants had been fasting for at least 8 h.
Using this data, the degree of insulin resistance was calculated according to the homeostasis model assessment (HOMA) which is a good index for assessing insulin resistance in subjects with different degree of insulin resistance and has a good correlation with insulin mediated glucose uptake calculated by euglycaemic hyperinsulinaemic glucose clamp [13±14].
According to the homeostasis model assessment (HOMA) [13±14], insulin resistance (IR) was calculated as follows: IR = FI´g/22.5; where FI = fasting insulin (mu/ml) and g = fasting glucose (mmol/l).
Baseline blood pressure was recorded by standard mercury sphygmomanometer. The disappearance of sound (phase V) was used for diastolic reading. All measurements were made with the subject in supine position, on three occasions separated by intervals of 2 min.; the mean value of the last two recorded measurements was considered for the analysis.
Analytical methods. Blood samples for insulin assay were collected in EDTA tubes and the plasma samples on the same day of collection was aliquoted in Eppendorf vials and stored at ±80 C until thawed for insulin assay. Plasma insulin was measured by a commercial double-antibody, solid phase radioimmunoassay (Sorin Biomedica, Milan Italy, intra-assay c. v. 3.1 + 0.3 %).
Serum glucose, serum lipid, serum lipoprotein, plasma iron and plasma fibrinogen were measured from fresh samples drawn after an overnight fast. The serum glucose concentration was measured by an enzymatic colorimetric assay using a modified glucose oxidase-peroxidase method (Roche Diagnostics, Mannheim, Germany) and a Roche-Hitachi 917 analyser.
Commercial enzymatic tests were used for determining serum total-and HDL cholesterol and triglyceride (Roche Diagnostics) concentrations. Serum LDL cholesterol concentrations were calculated by the Friedewald formula [15] . The interassay coefficient of variation was less than 3.8 % for total cholesterol, less 5.0 % for HDL cholesterol, less than 2.5 % for triglycerides.
Red blood cell count, white blood cells, platelets, haemoglobin concentration and hematocrit were done using a haematology autoanalyzer (SE 9000 DASIT). Serum iron concentration was determined by a colorimetric assay (Roche Diagnostics, Mannheim Germany) and a Roche-Hitachi 917 analyser.
Blood samples for fibrinogen test were collected in citrated tubes and the plasma fibrinogen concentrations were measured according to Clauss (STA Fibrinogen kit, Diagnostica Stago Roche Diagnostics) and a Sta Stago Boehringer Mannheim analyser.
Calculation and statistical analysis. To approximate normal distributions log-transformed values for plasma triglycerides, insulin and IR (HOMA) were used in the analysis. Pearson Product-moment correlations were calculated to test associations among variables. Impact of age on RBC, BMI, triglycerides, LDL cholesterol, haemoglobin and hematocrit was assessed by analysis of covariance (ANCOVA). To investigate the relation between red blood cell count, anthropometric and metabolic characteristics, data were stratified in quartiles of insulin resistance degree. ANOVA was used for calculating the p value for the trend for each variable among the different quartiles.
A cluster analysis showed whether an overall variable obtained by clustering variables of the insulin resistance syndrome was associated with RBC count. For this purpose, we created a compound score referred to as a clustering score, as the sum of Z-scores of the main variable of IR, BMI, triglycerides, LDL-cholesterol and HDL-cholesterol. A z-score indicates the position of an individual value of a variable in the total distribution of the variable in the population and is calculated as follows: (individual value ± mean value) over standard deviation. The association between this variable and red blood cell count was studied using linear regression.
Multivariate linear regression analysis was used to test the independent association of age, sex, BMI, WHR, plasma iron, drug intake, smoking habits and IR (HOMA) with red blood cell count.
Statistical analyses were done using an SPSS software package (Chicago, Ill., USA). All values are presented as Means SEM. A p value of less than 0.05 was considered to be statistically significant.
Results
The clinical characteristics of the study group are indicated in Table 1 . Subjects were old, slightly overweight with a mainly central body fat distribution.
In the whole group (n = 600), IR was positively correlated with BMI (r = 0.39 p < 0.001), plasma concentrations of triglycerides (r = 0.30 p < 0.001) and LDL-cholesterol (r = 0.14 p < 0.001) concentrations, and negatively correlated with concentrations of HDL-cholesterol (r = ±0.12 p < 0.005). A positive correlation between insulin, IR and the main haematological variables implicated in erythropoiesis was also found. In particular, insulin correlated with RBC (r = 0.11 p < 0.01) (Fig. 1) , plasma haemoglobin (r = 0.12 p < 0.003) concentrations, hematocrit (r = 0.15 p < 0.001) value and plasma iron (r = 0.11 p < 0.01) concentrations. Furthermore, IR correlated with RBC (r = 0.14 p < 0.001) (Fig. 1) , plasma haemoglobin (r = 0.16 p < 0.001) concentrations, hematocrit (r = 0.15 p < 0.001) value and plasma iron (r = 0.1 p < 0.05) concentrations. All these associations were still significant (p < 0.05) after adjustment for age (data not shown). IR was not associated with the number of white blood cells (WBC) (r = 0.01; p = 0.8) or platelet (r = ±0.07; p = 0.06).
Finally, a significant association of RBC count with the other main variables of insulin resistance syndrome was also found ( Fig. 1 and Table 2) .
Stratifying metabolic and anthropometric data for degree of IR, subjects with a higher degree of IR (4 quartile) had a higher RBC count, plasma triglycerides and LDL cholesterol concentrations and lower HDL cholesterol concentrations than subjects at the lowest quartiles of IR (Table 3) . Furthermore, the clustering analysis score of insulin resistance vari- As far as smoking habit is concerned, a prevalence of non-smokers was found (Table 1) . Furthermore, categorizing subjects in smokers and non-smokers, smoking subjects had a higher RBC count than nonsmokers (4.60 0.42 10 6 /mL vs 4.45 0.44 10 6 / mL; p < 0.01), indeed, no difference in HOMA index between smokers and no smokers (2.72 1.5 vs 2.80 1.4; p = 0.47) was found. Furthermore, subjects with a higher degree of IR (4 quartile) were mainly non-smokers (Table 3) .
A multivariate linear regression analyses with RBC count as a dependent variable and with a model made by age, sex, WHR, plasma iron, drugs intake and smoking habits showed that IR and BMI were predictors of RBC count when enclosed separately. In contrast, the same analysis including both BMI and IR showed that only BMI, age and sex had a significant association with RBC count (Table 4) .
Discussion
Our study provides evidence that hyperinsulinaemia/ insulin resistance is associated with increased RBC mass.
Various cytokines and growth factors regulate the development of mature RBC. Among such factors, erythropoietin is required for survival and differentiation of the erythropoietic progenitors [16] . Other growth factors including insulin have a synergistic effect together with erythropoietin on stimulating the proliferation of the erythroid colonies [17±19]. The role of insulin in the regulation of human erythropoiesis has been widely documented in vitro [5±9]. In fact, previous studies found that physiological concentrations of insulin directly stimulates the proliferation of late erythroid progenitors (CFU-E) in a culture of murine fetal liver [7] and promote growth in both human bone marrow and circulating erythroid progenitor cells in vitro [6±9] . The mechanism of the stimulatory effects of human insulin on human bone marrow CFU-E and BFU-E (burst forming unitserythroid) and the relation between insulin and erythropoietin have been previously investigated [8±9,20] . Briefly, the insulin receptor itself is thought to be involved in RBC proliferation and the insulin receptor (INS-R) has been detected on human erythropoietic cells at different stages of development, suggesting that human insulin acts at all stages of erythropoiesis [8] . Using a serum free system, it has [20] that insulin needs to bind with its own receptor before stimulating the erythroid progenitors, suggesting a direct action of this hormone on CFU-E and BFU-E. The most widely accepted theory explaining how insulin affects erythropoiesis is that activation of tyrosine kinase in the insulin receptor could be essential for the growth-promoting action of insulin [21±22] . Indeed, previous studies show that stimulation of insulin and erythropoietin receptors induces phosphorylation of a similar, although not identical, set of intracellular proteins with the activation of different signal transduction pathways [23±27] .
The in vivo relation between insulin and RBC count has been poorly documented. Indirect evidence comes from the data [28] showing that polycythaemia is often observed in newborn babies of diabetic mothers, probably because of the stimulatory effect of insulin on cord blood erythroid progenitors. Our study provides in vivo evidences of a relationship between hyperinsulinaemia/insulin resistance and RBC. Interestingly, a strong correlation between haematological parameters and the main variables of IR syndrome were also found, indicating that the increased RBC mass is a new additional feature of the IR syndrome. This is important because high RBC count is a strong independent predictor of acute cardiovascular events such as stroke and myocardial infarction [10] .
Because our findings were obtained from crosssectional data, the cause and effect relation is not clear. Nevertheless, some of the findings of our analysis support the hypothesis. Firstly, stratifying metabolic and anthropometric data for degree of IR, subjects with a higher degree of IR (4 quartile) had a higher red blood cell count, plasma triglycerides and LDL cholesterol concentrations and lower HDL cholesterol concentrations than subjects at the lowest quartiles of IR. Furthermore, in multivariate analysis IR was significantly associated with red blood cell count independently of age, sex, WHR, plasma iron, drug intake and smoking habits. Not surprisingly, this model explained only 18 % of variance because ± even though CFU-E requires insulin for erythroid development [18] ± insulin activity is synergistic with, but not alternative to, the effect of erythropoietin on growth of erithroid progenitors [8, 20, 29] . Indeed, although insulin should be considered a co-factor of erythropoietin, it had no effect on erythropoiesis in the absence of erythropoietin [8, 20] .
In our analysis, only BMI had a significant association with RBC count when both BMI and IR were enclosed in the same model. Such a result could be due to BMI rather than the degree of IR in the modulation of RBC count. Nevertheless, BMI is a strong predictor determinant of IR and it is therefore probable that the statistical relation occurring between the two variables (BMI and IR) results in the strongest one (BMI) weakening the effect or weight of the other (IR).
A potential impact of the smokers to non-smokers ratio on the effect of IR on RBC count cannot be ruled out. Our results did not, however, show a difference in the HOMA index between smokers and nonsmokers (p = NS) even though smokers had a higher RBC count than non-smokers (p < 0.01). Furthermore, subjects with a higher degree of IR (4th quartile) were mainly non-smokers (Table 3) . Finally, a multivariate linear regression analyses with an RBC count as a dependent variable showed that IR was a significant and independent predictor of RBC count even when the analysis was adjusted for smoking habits (Table 4) . Furthermore, in this analysis no significant association between smoking habit and RBC count was found.
Our study suggests that insulin might have a role in the treatment of haematological disorders due to erythropoietin resistance or inadequate erythropoietin concentrations. This hypothesis seems supported by in vitro results showing that human insulin has a stimulatory effect on erythroid progenitors independently of plasma erythropoietin concentrations [8] . Of note, the effect on haematological parameters will have to be weighed against the hypoglycaemic effect of insulin.
In conclusion, our study provides in vivo evidence of a relation between hyperinsulinaemia/insulin resistance, the main variables of IR syndrome, and haematological parameters thus suggesting an increased RBC count as a new aspect of the IR syndrome. Because the RBC count and mass greatly affect the rheologic properties of blood which, in turn, are strong independent predictors of major cardiovascular acute events [10] , the effect of hyperinsulinaemia on RBC could help explain the high rates of cardiovascular events that have been found in patients with the IR syndrome.
